NSC348884

CAS : 81624-55-7

Ref. 3D-GDA62455

Informations sur le produit

• Nom: NSC348884
• CAS: 81624-55-7

Description

NSC348884 is a novel anti-cancer drug that is an inhibitor of RNA polymerase. It has been shown to inhibit cellular transformation and viability in human leukemia HL-60 cells and prostate cancer cells, as well as inducing apoptosis. The mechanism of action of NSC348884 may be mediated through the induction of reactive oxygen species (ROS), activation of caspases, and modulation of signal transduction pathways. NSC348884 has also been shown to induce a variety of transcriptional effects on tumor cells, including upregulation or downregulation of genes involved in cell cycle regulation and apoptosis. This drug is also efficacious against brain tumors with malignant characteristics and breast cancer cells that are resistant to monoclonal antibody therapy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 636.79 g/mol
• Formule: C₃₈H₄₀N₁₀
• Degré de pureté: Min. 95%